［1］ PATTERSON RH,FISCHMAN VG,WASSERMAN I,et al.Global burden of head and neck cancer:Economic consequences,health,and the role of surgery［J］.Otolaryngol Head Neck Surg,2020,162(3):296-303.
［2］ ALSAHAFI E,BEGG K,AMELIO I.Clinical update on head and neck cancer:Molecular biology and ongoing challenges［J］.Cell Death Dis,2019,10(8):540.
［3］ ADIL MS,KHULOOD D,SOMANATH PR.Targeting Akt-associated microRNAs for cancer therapeutics［J］.Biochem Pharmacol,2021,189:114384.
［4］ LAI YH,LIU H,CHIANG WF,et al.MiR-31-5p-ACOX1 axis enhances tumorigenic fitness in oral squamous cell carcinoma via the promigratory prostaglandin E2［J］.Theranostics,2018,8(2):486-504.
［5］ LONDIN E,LOHER P,TELONIS AG,et al.Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs［J］.Proc Natl Acad Sci USA,2015,112(10):E1106-1115.
［6］ ISWARIYA GT,PAITAL B,PADMA PR,et al.microRNAs:Epigenetic players in cancer and aging［J］.Front Biosci (Schol Ed),2019,11:29-55.
［7］ JAVANDOOST E,FIROOZI-MAJD E,ROSTAMIAN H,et al.Role of microRNAs in chronic lymphocytic leukemia pathogenesis［J］.Curr Med Chem,2020,27(2):282-297.
［8］ LIU L,JIANG H,ZHAO J,et al.MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing wnt/β-catenin signaling pathway［J］.Onco Targets Ther,2018,11:5111-5119.
［9］ WANG X,LI GH.MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2［J］.J Cell Physiol,2018,233(12):9447-9457.
［10］ ZHAO J,FANG Z,ZHA Z,et al.Quercetin inhibits cell viability,migration and invasion by regulating miR-16/HOXA10 axis in oral cancer［J］.Eur J Pharmacol,2019,847:11-18.
［11］ HU S,WANG H,YAN D,et al.Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma［J］.Cell Cycle,2018,17(18):2284-2295.
［12］ HE Q,REN X,CHEN J,et al.miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways［J］.Oncotarget,2016,7(3):3047-3058.
［13］ CHEN WH,CAI MY,ZHANG JX,et al.FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1［J］.Oncogene,2018,37(48):6243-6258.
［14］ YOU H,WANG S,YU S.KIF9-AS1 promotes nasopharyngeal carcinoma progression by suppressing miR-16［J］.Oncol Lett,2020,20(5):241.
［15］ GIULIANELLI S,RIGGIO M,GUILLARDOY T,et al.FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences［J］.Int J Cancer,2019,145(7):1874-1888.
［16］ JIMENEZ-PASCUAL A,MITCHELL K,SIEBZEHNRUBL FA.FGF2:A novel druggable target for glioblastoma［J］.Expert Opin Ther Targets,2020,24(4):311-318.
［17］ JIANG Q,ZHANG Y,ZHAO M,et al.miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy［J］.Tumour Biol,2016,37(2):2425-2433.
［18］ DUAN L,YAN Y,WANG G,et al.ΜiR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6)［J］.J Buon,2020,25(5):2279-2286.
［19］ ZHANG C,FANG X,LI W,et al.Influence of recombinant lentiviral vector encoding miR-15a/16-1 in biological features of human nasopharyngeal carcinoma CNE-2Z cells［J］.Cancer Biother Radiopharm,2014,29(10):422-427.
［20］ LIU X,LUO HN,TIAN WD,et al.Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma［J］.Cancer Biol Ther,2013,14(12):1133-1142.
［21］ WU H,LIU T,WANG R,et al.MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2［J］.IUBMB life,2011,63(2):101-108.
［22］ LEGERSTEE K,GEVERTS B,SLOTMAN JA.Dynamics and distribution of paxillin,vinculin,zyxin and VASP depend on focal adhesion location and orientation［J］.Sci Rep,2019,9(1):10460.
［23］ KOTB A,HYNDMAN ME,PATEL TR.The role of zyxin in regulation of malignancies［J］.Heliyon,2018,4(7):e00695.
［24］ HU A,HUANG JJ,XU WH,et al.MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma［J］.Am J Cancer Res,2015,5(5):1775-1785.
［25］ XIE ZZ,XIAO ZC,SONG YX,et al.Long non-coding RNA Dleu2 affects proliferation,migration and invasion ability of laryngeal carcinoma cells through triggering miR-16-1 pathway ［J］.Eur Rev Med Pharmacol Sci,2018,22(7):1963-1970.
［26］ HUI L,WANG J,ZHANG J,et al.lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis［J］.PeerJ,2019,7:e7456.
［27］ HU J,LI C,LIU C,et al.Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC［J］.Cancer Biomark,2017,18(1):87-94.
［28］ YANG J.MicroRNA-16 Down-regulates BCL2 expression and induces papillary thyroid carcinoma cell apoptosis via extracellular-regulated kinase pathway［J］.Pak J Zool,2020,52(5):1675-1682.
［29］ XIONG H,YU H,JIA G,et al.circZFR regulates thyroid cancer progression by the miR-16/MAPK1 axis［J］.Environ Toxicol,2021,36(11):2236-2244.
［30］ FENG X,DONG X,WU D,et al.Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p［J］.Histol Histopathol,2020,35(2):217-224.
［31］ SANTOS PRB,COUTINHO-CAMILLO CM,SOARES FA,et al.MicroRNAs expression pattern related to mast cell activation and angiogenesis in paraffin-embedded salivary gland tumors［J］.Pathol Res Pract,2017,213(12):1470-1476.
［32］ FLORES BC,LOURENCO SV,DAMASCENA AS,et al.Altered expression of apoptosis-regulating miRNAs in salivary gland tumors suggests their involvement in salivary gland tumorigenesis［J］.Virchows Arch,2017,470(3):291-299.